RESUMO
BACKGROUND: Diarrhea because of Salmonella infection is a cause of neonatal calf diarrhea. The stimulation of passive immunity in the calf by vaccinating the dam for Salmonella has shown some success in previous studies; however, there are no data on the use of currently licensed vaccines in the United States. OBJECTIVE: To determine whether vaccinating cows at dry-off with a commercially available Salmonella bacterial extract would stimulate Salmonella-specific antibodies in the colostrum of cows at calving and whether these antibodies would be transferred to the calf. ANIMALS: Sixty Holstein cattle and 59 calves from a herd presumed to be naïve to Salmonella. METHODS: Prospective clinical trial. Thirty cows were vaccinated at dry-off with a Salmonella enterica serovar Newport bacterial extract and again 4 weeks later. An additional 30 cows received only saline. Calves fed fresh colostrum from their dam within 4 hours of birth had blood collected 24 hours later. RESULTS: Vaccinated cattle had increased Salmonella Newport antibody titers at calving in blood (P = .01) and colostrum (P = .011). Calves that received colostrum from vaccinated cattle also had significant increase in Salmonella antibodies (1.04 ± 0.03) as compared to calves born to unvaccinated cows (0.30 ± 0.02). CONCLUSIONS AND CLINICAL IMPORTANCE: The results indicate that the use of a commercially available Salmonella vaccine can stimulate antibodies that are passed on to the calf via colostral transfer. Further studies need to be done to determine whether these antibodies will offer protection against Salmonella challenge.
Assuntos
Doenças dos Bovinos/prevenção & controle , Imunização Passiva/veterinária , Salmonelose Animal/prevenção & controle , Vacinas contra Salmonella/uso terapêutico , Animais , Animais Recém-Nascidos/imunologia , Bovinos , Doenças dos Bovinos/imunologia , Doenças dos Bovinos/microbiologia , Colostro/imunologia , Feminino , Imunidade Materno-Adquirida/imunologia , Imunização Passiva/métodos , Gravidez , Salmonella/imunologia , Salmonelose Animal/imunologia , Vacinas contra Salmonella/imunologia , Vacinação/métodos , Vacinação/veterináriaRESUMO
BACKGROUND: Despite frequent clinical use, information about the pharmacokinetics and efficacy of pantoprazole in camelids is not available. OBJECTIVES: To examine the pharmacokinetics of both IV and SC pantoprazole and to determine whether pantoprazole administration would increase 3rd compartment pH in alpacas. ANIMALS: Six healthy adult alpacas. METHODS: Alpacas were fitted with a 3rd compartment cannula for measuring gastric pH. After recovery, alpacas received 1 mg/kg pantoprazole IV, q24h for 3 days or 2 mg/kg SC q24h for 3 days. Alpacas received both IV and SC pantoprazole, with a minimum of 3 weeks between treatments. Third compartment pH was recorded and plasma samples were taken for pharmacokinetic analysis. RESULTS: Pantoprazole induced a slow but sustained increase in 3rd compartment pH when given by both the IV and SC routes. Third compartment pH was significantly increased as compared with baseline values (1.81+/-0.7; mean+/-SD) at 24 (2.47+/-0.8), 48 (3.53+/-1.0) and 72 hours (4.03+/-1.3) after daily IV administration of pantoprazole. Third compartment pH increased from 1.73+/-0.6 at baseline to 3.05+/-1.1, 4.02+/-1.4, and 3.61+/-1.6 at 24, 48, and 72 hours after SC administration, respectively. Pharmacokinetic analysis demonstrated that pantoprazole had a short elimination half-life (0.47+0.06 h) and a high clearance rate (12.2+/-2.9 mL/kg/min) after both IV and SC administration. CONCLUSIONS AND CLINICAL RELEVANCE: Based on the results of this study, pantoprazole represents a safe and effective drug for increasing 3rd compartment pH in camelids. Either IV or SC administration is likely to be an effective treatment for gastric ulcers.
Assuntos
2-Piridinilmetilsulfinilbenzimidazóis/farmacocinética , 2-Piridinilmetilsulfinilbenzimidazóis/uso terapêutico , Antiulcerosos/farmacocinética , Antiulcerosos/uso terapêutico , Camelídeos Americanos , Úlcera Gástrica/veterinária , Animais , Concentração de Íons de Hidrogênio , Pantoprazol , Úlcera Gástrica/prevenção & controleRESUMO
A well-managed colostrum program on farms is the most important step in reducing disease in neonatal calves. In the last few years, colostrum replacers have increased in popularity and are designed to be an alternative to colostrum on farms that have poor colostrum quality, limited colostrum reserves, or to break the cycle of transmission for certain infectious diseases. However, it is important to make sure these products are effective and are capable of providing adequate serum immunoglobulin concentrations. The objective of this study was to evaluate the efficacy of a commercially available colostrum replacer product in dairy calves. Holstein calves from a single dairy were randomly assigned to 1 of 3 groups at birth. Group 1 (n = 21) calves were given 4 quarts of colostrum via esophageal feeder within 3 h of birth and served as the control group for this study. Group 2 (n = 21) received 2 packages of a colostrum replacer product, and group 3 (n = 21) received 3 packages of the colostrum replacer product within 3 h of birth. Blood samples from all calves were collected 24 h after colostrum administration and analyzed for serum total protein and IgG concentrations. Calves fed fresh colostrum had significantly higher serum total protein levels and IgG concentrations compared with calves fed the colostrum replacer product. Calves fed the colostrum replacer also had a significantly higher percentage of calves with failure of passive transfer (serum IgG <1,000 mg/dL). The colostrum replacer product evaluated in this study failed to routinely provide adequate IgG concentrations when fed according to label directions.
Assuntos
Proteínas Sanguíneas/farmacocinética , Bovinos/metabolismo , Imunoglobulina G/administração & dosagem , Imunoglobulina G/metabolismo , Absorção Intestinal/efeitos dos fármacos , Fenômenos Fisiológicos da Nutrição Animal , Animais , Animais Recém-Nascidos/sangue , Animais Recém-Nascidos/imunologia , Animais Recém-Nascidos/metabolismo , Proteínas Sanguíneas/metabolismo , Bovinos/sangue , Bovinos/imunologia , Colostro , Proteínas Alimentares/metabolismo , Proteínas Alimentares/farmacocinética , Imunização Passiva/métodos , Imunização Passiva/veterinária , Imunoglobulina G/sangue , Imunoglobulina G/imunologia , Absorção Intestinal/fisiologia , Distribuição AleatóriaRESUMO
Psyllium's effects on plasma and lipoprotein cholesterol concentrations, cholesterol metabolism, and diet-induced atherosclerosis were studied in adult male African green monkeys (Cercopithecus aethiops). Animals were fed for 3.5 y one of three experimental diets: low-cholesterol cellulose (LCC), high-cholesterol cellulose (HCC), or high-cholesterol psyllium (HCP). The LCC and HCP groups had significantly (P less than 0.05) lower plasma cholesterol concentrations (39% lower) at 1 mo than did the HCC group. These responses persisted throughout the study. Plasma cholesterol changes were due to a reduction in intermediate-density and low-density lipoproteins; very-low and high-density-lipoprotein concentrations were similar among groups. Aortic atherosclerosis, evaluated as percent sudanophilia at 3.5 y, was lowest in the LCC group, intermediate in the HCP group, and highest in the HCC group. Cholesterol absorption, neutral steroid and fat excretion, HMGCoA reductase activity (in intestine and liver), and body weight were unrelated to psyllium's hypocholesterolemic effects.
Assuntos
Arteriosclerose/dietoterapia , Colesterol/metabolismo , Fibras na Dieta/uso terapêutico , Lipoproteínas/sangue , Plantago , Plantas Medicinais , Animais , Arteriosclerose/sangue , Arteriosclerose/metabolismo , Chlorocebus aethiops , Colesterol/sangue , Colesterol na Dieta/administração & dosagem , Colesterol na Dieta/farmacocinética , Dieta Aterogênica , Modelos Animais de Doenças , Trânsito Gastrointestinal , Hidroximetilglutaril-CoA Redutases/análise , Absorção Intestinal , Intestinos/enzimologia , Fígado/enzimologia , Masculino , Distribuição Aleatória , Triglicerídeos/sangueRESUMO
Dietary psyllium's ability to reduce low-density-lipoprotein (LDL) cholesterol is presumably mediated by increased LDL catabolism and/or reduced LDL synthesis. To distinguish between these possibilities, apolipoprotein B (apo B) metabolism was studied in adult male African green monkeys consuming one of three semipurified diets: low-cholesterol cellulose (LCC), high-cholesterol cellulose (HCC), or high-cholesterol psyllium (HCP). 131I-labeled LDL and 125I-labeled VLDL were injected simultaneously into animals; blood samples were drawn at selected times and apo B specific activity determined in VLDL, IDL, and LDL. Based on a multicompartmental model, LDL apo B pool size and de novo apo B transport were elevated significantly in HCC animals compared with HCP and LCC animals. Differences in LDL transport, although not significant, paralleled differences observed in LDL apo B pool size. Fractional catabolic rates were similar among groups (HCC 0.040 +/- 0.010; HCP 0.042 +/- 0.009, and LCC 0.043 +/- 0.004 pools/h). These data suggest that dietary psyllium reduces plasma cholesterol concentrations by decreasing LDL synthesis.
Assuntos
Apolipoproteínas B/metabolismo , Fibras na Dieta/administração & dosagem , Plantago , Plantas Medicinais , Animais , Celulose/administração & dosagem , Chlorocebus aethiops , Colesterol/sangue , Colesterol na Dieta/administração & dosagem , HDL-Colesterol/sangue , LDL-Colesterol/sangue , Lipoproteínas/sangue , Lipoproteínas IDL , Lipoproteínas LDL/sangue , Lipoproteínas VLDL/sangue , Masculino , Triglicerídeos/sangueRESUMO
To account for the exchange of carbon atoms among alanine, lactate, and glucose in vivo, [2,3-3H]- and [U-14C]alanine or [3-3H]- and [U-14C]glucose were injected simultaneously to nonanesthetized normal dogs. The concentrations in plasma of 14C-labeled alanine, lactate, and glucose, and the injected 3H-labeled substrate were followed for 160 min after injection of the tracers. An integrated kinetic model describing the exchange of carbon atoms among substrates was developed from these data. The analysis suggests that there is a very rapid exchange of the carboxyl carbon of alanine with lactate in contrast to carbons 2 and 3. The model was used to calculate the fluxes of carbon atoms among the substrates in a steady state. In normal dogs plasma alanine and lactate contribute 14% of the carbon atoms released into the circulation as glucose.
Assuntos
Alanina/metabolismo , Glicemia/metabolismo , Carbono/metabolismo , Lactatos/metabolismo , Modelos Biológicos , Alanina/sangue , Animais , Carbono/sangue , Radioisótopos de Carbono , Computadores , Cães , Cinética , Lactatos/sangue , Trítio , UrânioRESUMO
The rates of transfer of carbon atoms (mg C . kg body wt-1 . min-1) among plasma glucose, alanine, and lactate have been calculated in pancreatectomized dogs from the tracer concentration versus time curves in the plasma after an intravenous injection of either [2,3-3H]- and [U-14C]alanine or [3-3H]- and [U-14C]glucose. The calculations were based on an integrated kinetic model derived earlier from experimental data. In comparison to normal dogs, in insulin-deprived pancreatectomized dogs, the rate of turnover of glucose (mg C . kg-1 . min-1) is increased about twofold, but the turnover rates of lactate and alanine are not changed significantly. About twice as much carbon is transferred from lactate to glucose, whereas the transfer of carbon from alanine is increased by 47%. Carbon transfer to glucose from unidentified sources is also doubled. In conclusion, in the pancreatectomized dog, gluconeogenesis is increased not by an increased production of alanine and lactate but by an increased diversion of their carbon atoms to glucose at the expense of other pathways.